Strain identifier

BacDive ID: 8259

Type strain: Yes

Species: Mycobacterium fortuitum

Strain Designation: Cruz 1, GB 178, Gdf M93, Lausanne 1021, X42, 140410001

Strain history: CIP <- 1995, V. Vincent, Inst. Pasteur, Paris, France: strain 14 041 0001

NCBI tax ID(s): 1214102 (strain), 1766 (species)

« back to strain detail view
For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 8.1 (current version)

General

@ref: 12593

BacDive-ID: 8259

DSM-Number: 46621

keywords: genome sequence, 16S sequence, Bacteria, obligate aerobe, mesophilic, human pathogen

description: Mycobacterium fortuitum Cruz 1 is an obligate aerobe, mesophilic human pathogen that was isolated from cold abscess, human.

NCBI tax id

NCBI tax idMatching level
1766species
1214102strain

strain history

@refhistory
327431995, V. Vincent, Inst. Pasteur, Paris, France: strain 14 041 0001
12593<- IMET <- R.E. Gordon (ATCC 6841)
67770M. Tsukamura 18112 <-- ATCC 6841 <-- R. Gordon (J. C. Cruz 1).
119439CIP <- 1995, V. Vincent, Inst. Pasteur, Paris, France: strain 14 041 0001

doi: 10.13145/bacdive8259.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Mycobacteriales
  • family: Mycobacteriaceae
  • genus: Mycobacterium
  • species: Mycobacterium fortuitum
  • full scientific name: Mycobacterium fortuitum da Costa Cruz 1938 (Approved Lists 1980)

  • synonyms

    • @ref: 20215
    • synonym: Mycolicibacterium fortuitum

@ref: 12593

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Actinomycetales

family: Mycobacteriaceae

genus: Mycobacterium

species: Mycobacterium fortuitum subsp. fortuitum

full scientific name: Mycobacterium fortuitum subsp. fortuitum (da Costa Cruz 1938) Tsukamura et al. 1986

strain designation: Cruz 1, GB 178, Gdf M93, Lausanne 1021, X42, 140410001

type strain: yes

Morphology

cell morphology

  • @ref: 119439
  • motility: no

colony morphology

  • @ref: 119439

multimedia

@refmultimedia contentintellectual property rightscaption
12593https://www.dsmz.de/microorganisms/photos/DSM_46621-1.jpg© Leibniz-Institut DSMZ
12593https://www.dsmz.de/microorganisms/photos/DSM_46621-2.jpg© Leibniz-Institut DSMZ
12593https://www.dsmz.de/microorganisms/photos/DSM_46621.jpg© Leibniz-Institut DSMZMedium 645 37°C

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
12593PEPTONE MEAT EXTRACT GLYCEROL AGAR (DSMZ Medium 250)yeshttps://mediadive.dsmz.de/medium/250Name: PEPTONE MEAT EXTRACT GLYCEROL AGAR (DSMZ Medium 250) Composition: Agar 20.0 g/l Proteose peptone no. 3 5.0 g/l Meat extract 3.0 g/l Glycerol Distilled water
12593MYCOBACTERIUM MEDIUM (DSMZ Medium 219)yeshttps://mediadive.dsmz.de/medium/219Name: MYCOBACTERIUM MEDIUM (DSMZ Medium 219) Composition: Agar 20.0 g/l Na2HPO4 x 12 H2O 2.5 g/l Yeast extract 2.0 g/l Proteose peptone no. 3 2.0 g/l Casein peptone 2.0 g/l Sodium citrate 1.5 g/l KH2PO4 1.0 g/l MgSO4 x 7 H2O 0.6 g/l Tween 0.5 g/l Glycerol Distilled water
12593MIDDLEBROOK MEDIUM (DSMZ Medium 645)yeshttps://mediadive.dsmz.de/medium/645Name: MIDDLEBROOK MEDIUM (DSMZ Medium 645) Composition: Bacto Middlebrook 7H10 agar 20.9945 g/l Glycerol Distilled water
32743MEDIUM 93 - for Mycobacterium avium subsp. sylvaticumyesDistilled water make up to (900.000 ml);Glycerol (4.500 ml);Middlebrook7H10 agar (17.000 g);Middelbrook OADC enrichment (100.000 ml)
119439CIP Medium 55yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=55
119439CIP Medium 93yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=93

culture temp

@refgrowthtypetemperaturerange
12593positivegrowth37mesophilic
32743positivegrowth30mesophilic
67770positivegrowth37mesophilic
119439positivegrowth22-37
119439nogrowth10psychrophilic
119439nogrowth45thermophilic

Physiology and metabolism

oxygen tolerance

  • @ref: 119439
  • oxygen tolerance: obligate aerobe

compound production

  • @ref: 12593
  • compound: restriction endonuclease MfoAI

observation

  • @ref: 67770
  • observation: quinones: MK-9(H2)

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
11943916947citrate-carbon source
1194394853esculin-hydrolysis
119439606565hippurate-hydrolysis
11943917632nitrate+reduction
11943916301nitrite-reduction
11943917632nitrate-respiration

antibiotic resistance

  • @ref: 119439
  • metabolite: 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)
  • is antibiotic: yes
  • is sensitive: yes
  • is resistant: no

metabolite production

  • @ref: 119439
  • Chebi-ID: 35581
  • metabolite: indole
  • production: no

metabolite tests

  • @ref: 119439
  • Chebi-ID: 15688
  • metabolite: acetoin
  • voges-proskauer-test: -

enzymes

@refvalueactivityec
119439oxidase-
119439beta-galactosidase-3.2.1.23
119439alcohol dehydrogenase-1.1.1.1
119439gelatinase-
119439amylase-
119439DNase-
119439caseinase-3.4.21.50
119439catalase+1.11.1.6
119439tween esterase-
119439gamma-glutamyltransferase-2.3.2.2
119439lecithinase-
119439lipase-
119439lysine decarboxylase-4.1.1.18
119439ornithine decarboxylase-4.1.1.17
119439protease-
119439tryptophan deaminase-
119439urease+3.5.1.5
68382alkaline phosphatase+3.1.3.1
68382esterase (C 4)+
68382esterase lipase (C 8)+
68382lipase (C 14)-
68382leucine arylamidase+3.4.11.1
68382valine arylamidase+
68382cystine arylamidase-3.4.11.3
68382trypsin-3.4.21.4
68382alpha-chymotrypsin-3.4.21.1
68382acid phosphatase+3.1.3.2
68382naphthol-AS-BI-phosphohydrolase+
68382alpha-galactosidase-3.2.1.22
68382beta-galactosidase-3.2.1.23
68382beta-glucuronidase-3.2.1.31
68382alpha-glucosidase-3.2.1.20
68382beta-glucosidase+3.2.1.21
68382N-acetyl-beta-glucosaminidase-3.2.1.52
68382alpha-mannosidase+3.2.1.24
68382alpha-fucosidase-3.2.1.51

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
119439-+++-++---++----+-+-

API biotype100

@refGLUFRUGALTREMNESBEMELSACRAFMTEMALLACLTEMbGaMaGaCELGENMbGuESCRIBARAXYLPLERHAFUCMLZDARLLARLXLTDULTAGGLYINOMANMTLTURSORADOHBGLYXERYMDG3MDGSATMUCLTATDTATMTATDMLTLMLTCATETATETTECITGRTGAT2KG5KGTRYNAGGNTPACPATpOBEQATGTEmOBEBATPPATCMTTGEBETPCEABTHINLATCAPCYTHISSUCFUMGREGYTAVTETNTTNGLNITA3OBUAPTGTTPRODALALALASERMNTPROPTYR2KT
119439++----------------+------------+-----------------+----------+-----------+-------+--++---+-+-----+--

Isolation, sampling and environmental information

isolation

@refsample typegeographic locationcountryorigin.countrycontinentisolation date
12593cold abscess, human
67770Cold abscess of human
119439Human, AbscessRio de JaneiroBrazilBRAMiddle and South America1937

isolation source categories

Cat1Cat2Cat3
#Host#Human
#Host Body-Site#Other#Abscess

Safety information

risk assessment

@refpathogenicity humanpathogenicity animalbiosafety levelbiosafety level comment
12593yesyes2Risk group (German classification)
1194392Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Mycobacterium fortuitum strain ATCC6841 16S ribosomal RNA (rrs) gene, partial sequenceAF059851171ena1214102
20218Mycobacterium fortuitum subsp. fortuitum strain CIP 104534 16S ribosomal RNA gene, partial sequenceAF547924540ena1214102
20218Mycobacterium fortuitum tyrS gene, 3-mag gene (partial) and 16S rRNA gene (partial), strain ATCC 6841AJ2961602397ena1214102
20218Mycobacterium fortuitum subsp. fortuitum 16S rRNA geneAJ5360391457ena1214102
20218M.fortuitum 16S ribosomal RNA geneM59282146ena1766
20218Mycobacterium fortuitum ATCC 6841, 16S ribosomal RNA gene, partial sequenceU92089880ena1214102
20218Mycobacterium fortuitum 16S rRNA geneX529331450ena1214102
12593Mycolicibacterium fortuitum subsp. fortuitum DSM 46621 = ATCC 6841 strain CIP 104534 16S ribosomal RNA gene, partial sequenceAY4570661483ena1214102

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Mycolicibacterium fortuitum subsp. fortuitum DSM 46621 = ATCC 6841 = JCM 6387GCA_001475495chromosomencbi1214102
66792Mycobacterium fortuitum subsp. fortuitum DSM 466211214102.3wgspatric1214102
66792Mycobacterium fortuitum subsp. fortuitum DSM 46621 = ATCC 68411214102.8wgspatric1214102
66792Mycobacterium fortuitum subsp. fortuitum DSM 46621 strain ATCC 68411214102.6wgspatric1214102
66792Mycolicibacterium fortuitum fortuitum DSM 466212519899744draftimg1214102
66792Mycolicibacterium fortuitum fortuitum ATCC 68412684623074completeimg1214102
66792Mycolicibacterium fortuitum fortuitum ATCC 68412706794657draftimg1214102
67770Mycolicibacterium fortuitum subsp. fortuitum DSM 46621 = ATCC 6841 = JCM 6387GCA_000295855scaffoldncbi1214102
67770Mycolicibacterium fortuitum subsp. fortuitum DSM 46621 = ATCC 6841 = JCM 6387GCA_001050075scaffoldncbi1214102
66792Mycolicibacterium fortuitum subsp. fortuitum JCM 6387GCA_022179545completencbi144549

GC content

  • @ref: 67770
  • GC-content: 66.4
  • method: genome sequence analysis

External links

@ref: 12593

culture collection no.: DSM 46621, ATCC 6841, CCUG 20994, CIP 104534, IFO 13159, IMET 10605, JCM 6387, NBRC 13159, NCTC 10394, TMC 1529, RIMD 1317004, Tsukamura 18112, CCUG 27973, KCTC 9510, PCM 672

straininfo link

  • @ref: 77661
  • straininfo: 92782

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Phylogeny1581184Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov.Kusunoki S, Ezaki TInt J Syst Bacteriol10.1099/00207713-42-2-2401992Colorimetry, DNA, Bacterial, Mycobacterium/*classification/genetics, Mycobacterium chelonae/*classification/genetics, Nucleic Acid Hybridization, PhenotypePhenotype
Pathogenicity3213316Morphological changes in Mycobacterium fortuitum induced by ofloxacin.Saito H, Watanabe T, Hirata TZentralbl Bakteriol Mikrobiol Hyg A10.1016/s0176-6724(88)80122-61988Anti-Bacterial Agents/*pharmacology, Microscopy, Electron/methods, Microscopy, Electron, Scanning/methods, Mycobacterium/drug effects/*ultrastructure, Ofloxacin/*pharmacology
Pathogenicity11425542Some 3-thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials.Kucukguzel I, Kucukguzel SG, Rollas S, Kiraz MBioorg Med Chem Lett10.1016/s0960-894x(01)00283-92001Animals, Antitubercular Agents/chemistry/*pharmacology, Chlorocebus aethiops, Microbial Sensitivity Tests, Mycobacterium fortuitum/*drug effects, Mycobacterium tuberculosis/*drug effects, Thiourea/*chemistry, Triazoles/chemistry/*pharmacology, Vero Cells
Cultivation14744453Characterization of the susceptibility of mycobacteria in BACTEC 12B media containing PANTA that had been supplemented with ceftazidime, and characterization of the individual components of PANTA in the presence of C18-carboxypropylbetaine.Thornton CG, MacLellan KM, Brink TL, Passen SJ Microbiol Methods10.1016/j.mimet.2003.10.0202004Anti-Bacterial Agents/*pharmacology, Azlocillin/pharmacology, Bacteriological Techniques/*methods, Betaine/*analogs & derivatives/*pharmacology, Ceftazidime/*pharmacology, Culture Media, Mycobacterium/*drug effects/growth & development, Nalidixic Acid/pharmacology, Polymyxin B/pharmacology, Trimethoprim/pharmacologyPathogenicity
Pathogenicity15590712Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum.Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ JrJ Antimicrob Chemother10.1093/jac/dkh5232004Amino Acid Sequence, Drug Resistance, Bacterial/drug effects/*genetics, Humans, Macrolides/*pharmacology, Molecular Sequence Data, Mycobacterium fortuitum/drug effects/*genetics/*isolation & purificationGenetics
15777648Murine infection model for Mycobacterium fortuitum.Parti RP, Srivastava S, Gachhui R, Srivastava KK, Srivastava RMicrobes Infect10.1016/j.micinf.2004.11.0062005Animals, Cell Line, *Disease Models, Animal, Female, Kidney/microbiology/pathology, Macrophages/microbiology, Macrophages, Peritoneal/microbiology, Mice, Mice, Inbred BALB C, Mycobacterium Infections, Nontuberculous/pathology/*physiopathology, *Mycobacterium fortuitum, Virulence
Pathogenicity18536176Pyrido-1,2-thiazines and their in vitro antibacterial evaluation.Malinka W, Gamian A, Redzicka A, Swiatek PActa Pol Pharm2008Anti-Bacterial Agents/chemical synthesis/*pharmacology, Microbial Sensitivity Tests, Mycobacterium fortuitum/drug effects, Pyridines/chemical synthesis/*pharmacology, Staphylococcus aureus/drug effects, Structure-Activity Relationship, Thiazines/chemical synthesis/*pharmacology
Pathogenicity18930129A transposon insertion mutant of Mycobacterium fortuitum attenuated in virulence and persistence in a murine infection model that is complemented by Rv3291c of Mycobacterium tuberculosis.Parti RP, Shrivastava R, Srivastava S, Subramanian AR, Roy R, Srivastava BS, Srivastava RMicrob Pathog10.1016/j.micpath.2008.08.0082008Animals, DNA Transposable Elements, Disease Models, Animal, Female, Genetic Complementation Test, Humans, Kidney/microbiology, Mice, Mice, Inbred BALB C, Molecular Sequence Data, *Mutagenesis, Insertional, *Mutation, Mycobacterium Infections, Nontuberculous/*microbiology, Mycobacterium fortuitum/genetics/metabolism/*pathogenicity, Transcription Factors/genetics/*metabolism, VirulenceGenetics
Pathogenicity19051602Synthesis and studies on antibacterial activity of pyrido[3,2-e]-1,2-thiazines and related derivatives.Malinka W, Gamian A, Szczesniak-Siega BActa Pol Pharm2008Anti-Bacterial Agents/*chemical synthesis/pharmacology, Microbial Sensitivity Tests, Mycobacterium fortuitum/drug effects, Staphylococcus aureus/drug effects, Structure-Activity Relationship, Thiazines/*chemical synthesis/pharmacology
Cultivation22197720Comparative study with two different enrichments in the culture media used in the disinfectant efficacy assay.Sabagh BP, Souto Ada S, Reis LM, Silva SA, Pereira DC, Neves Mde C, Pinheiro RR, Duarte RS, Miyazaki NH, Boas MHJ Microbiol Methods10.1016/j.mimet.2011.12.0042011Animals, Brazil, Cattle, Culture Media/*chemistry, Disinfectants/*pharmacology, Glucose/pharmacology, Glutaral/pharmacology, Microbial Sensitivity Tests/*methods, Mycobacterium/*drug effects/growth & development, Statistics, NonparametricPathogenicity
Genetics23105073Complete genome sequence of Mycobacterium fortuitum subsp. fortuitum type strain DSM46621.Ho YS, Adroub SA, Aleisa F, Mahmood H, Othoum G, Rashid F, Zaher M, Ali S, Bitter W, Pain A, Abdallah AMJ Bacteriol10.1128/JB.01461-122012*Genome, Bacterial, Molecular Sequence Data, Mycobacterium fortuitum/*classification/*geneticsPhylogeny
Pathogenicity23850103Synthesis of novel isothiazolopyridines and their in vitro evaluation against Mycobacterium and Propionibacterium acnes.Malinka W, Swiatek P, Sliwinska M, Szponar B, Gamian A, Karczmarzyk Z, Fruzinski ABioorg Med Chem10.1016/j.bmc.2013.06.0272013Animals, Antitubercular Agents/*chemical synthesis/chemistry/pharmacology, Cell Survival/drug effects, Chlorocebus aethiops, Crystallography, X-Ray, Microbial Sensitivity Tests, Molecular Conformation, Mycobacterium/drug effects, Mycobacterium tuberculosis/drug effects, Propionibacterium acnes/drug effects, Pyridines/chemical synthesis/*chemistry/pharmacology, Structure-Activity Relationship, Thiazoles/*chemistry, Vero Cells
Pathogenicity23882726[Comparative evaluation of acid-fast staining for the detection of Mycobacterium fortuitum--clinical performance of fluorescent and Ziehl-Neelsen staining].Yoshida S, Tsuyuguchi K, Suzuki K, Tomita M, Okada M, Hayashi S, Arikawa K, Iwamoto TKekkaku2013*Coloring Agents, *Fluorescence, Humans, Mycobacterium fortuitum/cytology/*isolation & purification, Sequence Analysis, RNA, Time FactorsTranscriptome
Genetics27375559Comparative Genomics and Proteomic Analysis of Four Non-tuberculous Mycobacterium Species and Mycobacterium tuberculosis Complex: Occurrence of Shared Immunogenic Proteins.Gcebe N, Michel A, Gey van Pittius NC, Rutten VFront Microbiol10.3389/fmicb.2016.007952016
Pathogenicity27567903Identification of antimicrobial activity among new sulfonamide metal complexes for combating rapidly growing mycobacteria.Agertt VA, Bonez PC, Rossi GG, Flores Vda C, Siqueira Fdos S, Mizdal CR, Marques LL, de Oliveira GN, de Campos MMBiometals10.1007/s10534-016-9951-32016Anti-Bacterial Agents/chemical synthesis/chemistry/*pharmacology, Coordination Complexes/chemical synthesis/chemistry/*pharmacology, Dose-Response Relationship, Drug, Metals, Heavy/chemistry/*pharmacology, Microbial Sensitivity Tests, Mycobacterium/*drug effects/*growth & development, Structure-Activity Relationship, Sulfonamides/chemistry/*pharmacology
Pathogenicity29122674Antibiofilm activity of nanoemulsions of Cymbopogon flexuosus against rapidly growing mycobacteria.Rossi GG, Guterres KB, Bonez PC, da Silva Gundel S, Aggertt VA, Siqueira FS, Ourique AF, Wagnerd R, Klein B, Santos RCV, de Campos MMAMicrob Pathog10.1016/j.micpath.2017.11.0022017Anti-Bacterial Agents/*pharmacology, Biofilms/*drug effects/growth & development, Brazil, Cymbopogon/*chemistry, Emulsions, Microbial Sensitivity Tests, Nontuberculous Mycobacteria/*drug effects, Oils, Volatile/chemistry/*pharmacology, Plant Exudates/*pharmacology, Plant Oils/chemistry/pharmacology
Pathogenicity31481764Inhibition of Mycobacterium abscessus, M. chelonae, and M. fortuitum biofilms by Methylobacterium sp.Garcia-Coca M, Rodriguez-Sevilla G, Perez-Domingo A, Aguilera-Correa JJ, Esteban J, Munoz-Egea MCJ Antibiot (Tokyo)10.1038/s41429-019-0232-62019Anti-Bacterial Agents/*isolation & purification/*pharmacology, Biofilms/*drug effects, Colony Count, Microbial, Methylobacterium/*chemistry, Microbial Sensitivity Tests, Microscopy, Confocal, Mycobacterium/*drug effects, Mycobacterium abscessus/drug effectsEnzymology
Metabolism31727369Random insertion transposon mutagenesis of Mycobacterium fortuitum identified mutant defective in biofilm formation.Katoch P, Gupta K, Yennamalli RM, Vashistt J, Bisht GS, Shrivastava RBiochem Biophys Res Commun10.1016/j.bbrc.2019.11.0212019Anthranilate Phosphoribosyltransferase/chemistry/metabolism, Bacterial Proteins/chemistry/metabolism, Biofilms/*growth & development, Chorismic Acid/metabolism, DNA Transposable Elements/*genetics, Mutagenesis, Insertional/*genetics, Mutation/*genetics, Mycobacterium fortuitum/*genetics/*physiology, Protein Interaction Mapping, Protein Structure, Secondary
32810554Peripheral tetra-cationic Pt(II) porphyrins photo-inactivating rapidly growing mycobacteria: First application in mycobacteriology.Rossi GG, Guterres KB, da Silveira CH, Moreira KS, Burgo TAL, Iglesias BA, de Campos MMAMicrob Pathog10.1016/j.micpath.2020.1044552020Cations, Light, *Mycobacterium, Photosensitizing Agents/pharmacology, *Porphyrins
34481062Photo-damage promoted by tetra-cationic palladium(II) porphyrins in rapidly growing mycobacteria.Rossi GG, Guterres KB, Moreira KS, Burgo TAL, de Campos MMA, Iglesias BAPhotodiagnosis Photodyn Ther10.1016/j.pdpdt.2021.1025142021*Mycobacterium, Palladium, *Photochemotherapy/methods, Photosensitizing Agents/pharmacology, *Porphyrins/pharmacology
Genetics35357161Complete Genome Sequence of Mycobacterium fortuitum subsp. fortuitum JCM 6387, a Type Strain of Human-Pathogenic Mycobacteria Showing Inducible Macrolide Resistance.Yoshida M, Fukano H, Suzuki M, Hoshino YMicrobiol Resour Announc10.1128/mra.00060-222022

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
12593Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 46621)https://www.dsmz.de/collection/catalogue/details/culture/DSM-46621
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
32743Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/16453
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68382Automatically annotated from API zym
77661Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID92782.1StrainInfo: A central database for resolving microbial strain identifiers
119439Curators of the CIPCollection of Institut Pasteur (CIP 104534)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%20104534